Philips (ADR) (PHG)
Builds clinical imaging, connected-care systems, respiratory equipment, and personal-health devices.
$24.48
vs last close−0.49 (−1.96%)
In millions of USD, except per-share figures · converted from EUR at the latest rate
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,089 | 5,761 | 4,710 | 5,079 | 4,982 | 5,741 | 4,663 | 4,937 | 4,896 | 5,801 | 4,445 | 4,962 |
| Cost of revenue | 2,889 | 3,714 | 2,644 | 2,815 | 2,699 | 3,507 | 2,559 | 2,649 | 2,723 | 3,197 | 2,436 | 2,515 |
| Gross profit | 2,200 | 2,048 | 2,066 | 2,264 | 2,283 | 2,234 | 2,104 | 2,289 | 2,174 | 2,604 | 2,010 | 2,447 |
| 1,945 | 2,020 | 3,004 | 1,335 | 1,900 | 2,008 | 1,929 | 1,834 | 1,798 | 1,990 | 1,735 | 1,753 | |
| Research & development | 506 | 868 | 477 | 483 | 493 | 537 | 520 | 458 | 471 | 486 | 448 | 551 |
| 1,439 | 1,551 | 1,402 | 1,463 | 1,395 | 1,508 | 1,420 | 1,410 | 1,341 | 1,485 | 1,348 | 1,374 | |
| Selling & marketing | 1,268 | 1,389 | 1,247 | 1,283 | 1,224 | 1,352 | 1,237 | 1,234 | 1,165 | 1,305 | 1,146 | 1,198 |
| General & administrative | 171 | 163 | 155 | 180 | 172 | 156 | 183 | 176 | 175 | 180 | 201 | 175 |
| Other expenses | 0 | −399 | 1,125 | −610 | 11 | −38 | −11 | −34 | −14 | 18 | −61 | −172 |
| Operating income | 255 | 27 | −938 | 929 | 384 | 226 | 175 | 455 | 376 | 615 | 274 | 694 |
| −108 | −134 | −80 | −182 | −102 | −94 | −56 | −72 | −63 | −84 | −58 | −73 | |
| Interest income | 17 | 0 | 27 | 23 | 39 | 6 | 38 | 26 | 24 | 43 | 40 | 38 |
| Interest expense | 104 | 17 | 107 | 100 | 118 | 65 | 93 | 91 | 89 | 123 | 94 | 108 |
| Other non-operating income | 3 | −606 | −1 | 612 | −16 | 1 | −36 | −19 | −2 | −39 | −36 | −35 |
| Income before tax | 147 | −107 | −1,018 | 747 | 281 | 132 | 120 | 384 | 313 | 530 | 216 | 621 |
| Income tax expense | 36 | −150 | 120 | 393 | 74 | 511 | 31 | 108 | 99 | 83 | 50 | 182 |
| Net income from continuing operations | 110 | 43 | −1,137 | 354 | 207 | −379 | 89 | 275 | 214 | 447 | 166 | 439 |
| Discontinued operations | −8 | −1 | 1 | 160 | 0 | 0 | −7 | −2 | −1 | 5 | 0 | 0 |
| Other adjustments | 0 | 0 | −1 | 1 | −1 | −1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 100 | 44 | −1,137 | 513 | 206 | −381 | 87 | 273 | 209 | 450 | 172 | 437 |
| EPS, basic | $0.11 | $0.05 | −$1.24 | $0.55 | $0.23 | −$0.41 | $0.09 | $0.28 | $0.22 | $0.47 | $0.18 | $0.46 |
| EPS, diluted | $0.11 | $0.05 | −$1.22 | $0.55 | $0.23 | −$0.41 | $0.09 | $0.28 | $0.22 | $0.47 | $0.18 | $0.46 |
| Weighted average shares, basic | 934 | 935 | 913 | 939 | 902 | 928 | 925 | 946 | 964 | 963 | 952 | 956 |
| Weighted average shares, diluted | 948 | 935 | 937 | 942 | 913 | 929 | 938 | 957 | 964 | 966 | 969 | 969 |
| EBITDA | 252 | 835 | −735 | 679 | 399 | 621 | 526 | 777 | 723 | 971 | 612 | 1,163 |
| Depreciation & amortization | 0 | 202 | 202 | 363 | 0 | 396 | 314 | 303 | 345 | 318 | 302 | 434 |
| EBIT | 252 | 633 | −937 | 316 | 399 | 225 | 212 | 475 | 378 | 653 | 311 | 730 |